Ischemic stroke patients treated on a mobile stroke unit (MSU) received anti-clot medication faster and ended up with less disability at 90 days, according to a study published today in the New England Journal of Medicine led by researchers at The University of Texas Health Science Center at Houston (UTHealth Houston) and Memorial Hermann-Texas Medical Center.

Women are less likely than men to receive timely care for strokes caused by blockages in large vessels, known as emergent large vessel occlusion (ELVO), according to researchers with The University of Texas Health Science Center at Houston (UTHealth).

MedPage Today covered research by Amrou Sarraj, MD, showing that stroke patients had better clinical outcomes when they skipped having a CT scan upon arrival at a hospital and instead received an angiography test.

In February 2020, Lewis Palmer's friends and family noticed something didn't sound right in his voice. The 46-year-old from Baton Rouge, Louisiana was hoarse and his speech was slightly slurred. 

New artificial intelligence technology that uses a common CT angiography (CTA) as opposed to the more advanced imaging normally required to help identify patients who could benefit from endovascular stroke therapy (EST) is being developed at UTHealth. 

Juliana Gomez, MD, spoke to Univision Houston Channel 45 about stroke incidence among the Hispanic population and common signs and symptoms to look for. 

Tahani Casameni-Montiel, BBA, RN, was interviewed by VeryWell Health about “RAPIDO,” the early sign and symptom stroke recognition tool developed by researchers at Cizik School of Nursing under the guidance of Jennifer Beauchamp, PhD, RN.

Stroke patients received clot-busting medications such as tissue plasminogen activator (tPA) faster, more often, and recovered significantly better when treated via a mobile stroke unit (MSU) compared to standard management by Emergency Medical Services (EMS), according to researchers with The University of Texas Health Science Center at Houston (UTHealth) and Memorial Hermann-Texas Medical Center (TMC).

Researchers with The University of Texas Health Science Center at Houston (UTHealth) have created an acronym, RAPIDO^(c), to move forward much-needed efforts to address stroke sign and symptom awareness among at-risk Spanish-speaking individuals.

Zaundra Martinez, a mother of two Girl Scouts, marks the UTHealth Girl Scouts Stomp Out Stroke Program event on her family’s calendar each year. After suffering multiple strokes in 2008, Martinez wanted to ensure her daughters are prepared to respond quickly if another one strikes.

In the first of its kind for the tiniest stroke survivors, researchers at The University of Texas Health Science Center at Houston (UTHealth) will lead a stroke rehabilitation clinical trial in the state of Texas through a multi-institutional NIH StrokeNet initiative.

During a time when many people are delaying appropriate health care due to fear of COVID-19, Patricia Miata, 58, says timely treatment is ultimately what saved her life after suffering a stroke.

Anjail Sharrief, MD, MPH, was appointed to a citywide COVID-19 response task force.

Sean Savitz, MD, was quoted in a KTRK-TV Channel 13 online story about how the drop in ER stroke visits could mean people aren't seeking needed help.

Timely treatment is critical for stroke victims, yet only 19.8% of the U.S. population can access a stroke center capable of endovascular thrombectomy to remove a large clot in 15 minutes or less by ambulance, according to researchers from UTHealth. Only 30% of Americans can access a thrombectomy-equipped center in 30 minutes.

A regulator of gene expression, retinoid X receptor (RXR), can boost scavenging cells in their mission to clear the brain of dead cells and debris after a stroke, thus limiting inflammation and improving recovery, according to preclinical research led by Jarek Aronowski, MD, PhD, of The University of Texas Health Science Center at Houston (UTHealth).

Both simple and advanced computed tomography (CT) were effective in accurately predicting which stroke patients would benefit from endovascular thrombectomy to remove a large cerebral clot, but together they were even better, reported researchers at The University of Texas Health Science Center at Houston (UTHealth).

Luca Giancardo, PhD, assistant professor at UTHealth School of Biomedical Informatics, has been awarded one of six grants from Baylor College of Medicine’s Translational Research Institute for Space Health. 

An algorithm developed by UTHealth faculty can help physicians outside of major stroke treatment centers assess whether a patient suffering from ischemic stroke would benefit from an endovascular procedure to remove a clot blocking an artery.

Researchers led by Sean I. Savitz, MD, reported today in the journal Stem Cells that bone marrow cells used to treat ischemic stroke in an expanded Phase I trial were not only safe and feasible, but also resulted in enhanced recovery compared to a matched historical control group.

Researchers at UTHealth recently published new findings in Stroke that show patients transported to the hospital by mobile stroke unit instead of standard ambulance received a clot-busting procedure an average of 10 minutes faster, which could potentially save up to 270 million neurons per patient.

The UTHealth Stomp Out Stroke Festival has been rescheduled to Saturday, June 8. The free, fun event will take place, as previously, from 9 a.m. to 3:30 p.m. at Discovery Green’s Jones Lawn.

Outcomes in patients treated with mechanical clot removal, results from the only mobile stroke unit in the country using rendezvous transfers, and data on predictors of post-stroke depression and anxiety were among the highlights of activity by investigators from UTHealth at the International Stroke Conference 2019.

The International Stroke Conference (ISC) attracts thousands of neurologists each year to network with fellow experts and watch compelling presentations on the very latest advances in clinical care, science, and education. 

The first U.S. patient to participate in a global study of a stem cell therapy injected directly into the brain to treat stroke disability was enrolled in the clinical trial this week at UTHealth.

A new global clinical trial studying stem cell therapy for stroke disability led by Sean I. Savitz, MD, was picked up by 11 media outlets including Financial Times, News Medical, and Medical Xpress. You can also read more in the Newsroom.